39 related articles for article (PubMed ID: 33427075)
1. Molecular insights in repurposing selective COX-2 inhibitor celecoxib against matrix metalloproteinases in potentiating delayed wound healing: a molecular docking and MMPB/SA based analysis of molecular dynamic simulations.
Mude L; Jupudi S; Swaroop AK; Tallapaneni V; Karri VVSR
J Biomol Struct Dyn; 2024 Mar; 42(5):2437-2448. PubMed ID: 37160705
[TBL] [Abstract][Full Text] [Related]
2. Exploring molecular docking with MM-GBSA and molecular dynamics simulation to predict potent inhibitors of cyclooxygenase (COX-2) enzyme from terpenoid-based active principles of
Nayak A; Gadnayak A; Dash KT; Jena S; Ray A; Nayak S; Sahoo A
J Biomol Struct Dyn; 2023 Dec; 41(20):10840-10850. PubMed ID: 36576262
[TBL] [Abstract][Full Text] [Related]
3. Discovery of andrographolide hit analog as a potent cyclooxygenase-2 inhibitor through consensus MD-simulation, electrostatic potential energy simulation and ligand efficiency metrics.
Jain P; Satija J; Sudandiradoss C
Sci Rep; 2023 May; 13(1):8147. PubMed ID: 37208387
[TBL] [Abstract][Full Text] [Related]
4. Precise cuts for tailoring chromene-phenyl COX inhibitors with Ligand Designer.
Vo HHN; Phung THT; Chung KL; Vu TY
J Mol Graph Model; 2024 Jun; 129():108747. PubMed ID: 38447296
[TBL] [Abstract][Full Text] [Related]
5. Development of novel chromones as antioxidant COX2 inhibitors:
Lakkadi A; Vuppala S; Nampally V; Kim J; Kim K; Jang J; Tigulla P
J Biomol Struct Dyn; 2024 Apr; 42(6):2793-2808. PubMed ID: 37184132
[TBL] [Abstract][Full Text] [Related]
6. Repurposing Drugs for Inhibition against ALDH2 via a 2D/3D Ligand-Based Similarity Search and Molecular Simulation.
Jiang W; Chen J; Zhang P; Zheng N; Ma L; Zhang Y; Zhang H
Molecules; 2023 Oct; 28(21):. PubMed ID: 37959744
[TBL] [Abstract][Full Text] [Related]
7. Computer-aided analysis for identification of novel analogues of ketoprofen based on molecular docking, ADMET, drug-likeness and DFT studies for the treatment of inflammation.
Bettadj FZY; Benchouk W
J Biomol Struct Dyn; 2023 Nov; 41(19):9915-9930. PubMed ID: 36444967
[TBL] [Abstract][Full Text] [Related]
8. Virtual screening and invitro evaluation of cyclooxygenase inhibitors from
Mathe A; Mulpuru V; Katari SK; Karlapudi AP; T C V
J Biomol Struct Dyn; 2023 Oct; ():1-15. PubMed ID: 37904339
[No Abstract] [Full Text] [Related]
9. Explainable artificial intelligence-assisted virtual screening and bioinformatics approaches for effective bioactivity prediction of phenolic cyclooxygenase-2 (COX-2) inhibitors using PubChem molecular fingerprints.
Rudrapal M; Kirboga KK; Abdalla M; Maji S
Mol Divers; 2024 Jan; ():. PubMed ID: 38200203
[TBL] [Abstract][Full Text] [Related]
10. Insights from the docking analysis of biologically active compounds from plant Litsea Genus as potential COX-2 inhibitors.
Gogoi D; Bezbaruah RL; Bordoloi M; Sarmah R; Bora TC
Bioinformation; 2012; 8(17):812-5. PubMed ID: 23139590
[TBL] [Abstract][Full Text] [Related]
11. Virtual screening of 2,3-disubstituted-4(3H)-quinazolinones possessing benzenesulfonamide moiety for COX-2 inhibitor.
Hayun ; Yanuar A; Hanafi M; Pws SH
Bioinformation; 2011; 7(5):246-50. PubMed ID: 22125393
[TBL] [Abstract][Full Text] [Related]
12. An Activity-Based Sensing Approach for the Detection of Cyclooxygenase-2 in Live Cells.
Yadav AK; Reinhardt CJ; Arango AS; Huff HC; Dong L; Malkowski MG; Das A; Tajkhorshid E; Chan J
Angew Chem Int Ed Engl; 2020 Feb; 59(8):3307-3314. PubMed ID: 31854058
[TBL] [Abstract][Full Text] [Related]
13. Analgesic Activity of 5-Acetamido-2-Hydroxy Benzoic Acid Derivatives and an In-Vivo and In-Silico Analysis of Their Target Interactions.
Santos CBR; Lobato CC; Ota SSB; Silva RC; Bittencourt RCVS; Freitas JJS; Ferreira EFB; Ferreira MB; Silva RC; De Lima AB; Campos JM; Borges RS; Bittencourt JAHM
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004449
[TBL] [Abstract][Full Text] [Related]
14. Inhibition Kinetics and Theoretical Studies on
Kimani NM; Ochieng CO; Ogutu MD; Yamo KO; Onyango JO; Santos CBR
J Xenobiot; 2023 Feb; 13(1):102-120. PubMed ID: 36976158
[TBL] [Abstract][Full Text] [Related]
15. The Inhibitors of CDK4/6 from a Library of Marine Compound Database: A Pharmacophore, ADMET, Molecular Docking and Molecular Dynamics Study.
Luo L; Wang Q; Liao Y
Mar Drugs; 2022 May; 20(5):. PubMed ID: 35621970
[TBL] [Abstract][Full Text] [Related]
16. Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro.
Silva RC; Freitas HF; Campos JM; Kimani NM; Silva CHTP; Borges RS; Pita SSR; Santos CBR
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769170
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel potential cyclooxygenase-2 inhibitors using ligand- and structure-based virtual screening approaches.
Cruz JV; Giuliatti S; Alves LB; Silva RC; Ferreira EFB; Kimani NM; Silva CHTP; Souza JSN; Espejo-Román JM; Santos CBR
J Biomol Struct Dyn; 2022 Aug; 40(12):5386-5408. PubMed ID: 33427075
[TBL] [Abstract][Full Text] [Related]
18. Identification of New Rofecoxib-Based Cyclooxygenase-2 Inhibitors: A Bioinformatics Approach.
Leão RP; Cruz JV; da Costa GV; Cruz JN; Ferreira EFB; Silva RC; de Lima LR; Borges RS; Dos Santos GB; Santos CBR
Pharmaceuticals (Basel); 2020 Aug; 13(9):. PubMed ID: 32858871
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
